AI assistant
Sending…
Cellectar Biosciences, Inc. — Director's Dealing 2019
Mar 11, 2019
35021_dirs_2019-03-11_bf65dc36-f094-408a-b325-0058e09c2eb0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2019-03-09
Reporting Person: Bernhardt Charles Thomas III (Interim CFO)
More from Cellectar Biosciences, Inc.
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Mar 4
Annual Report
2026
Mar 4
Major Shareholding Notification
2026
Feb 10
Major Shareholding Notification
2026
Feb 4